Prospective clinical study for Yuyang Capsule combined with HAART intervention in HIV-infected patients
Phase 1
Recruiting
- Conditions
- AIDS
- Registration Number
- ITMCTR1900002404
- Lead Sponsor
- Sichuan Provincial Administration of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Aged 18 to 65 years;
2. HIV-infected patients who meet the diagnostic criteria of the Third Edition of HIV/AIDS Guidelines (2015 Edition);
3. Baseline CD4 cell count >=200/ul;
4. Start HAART time >=6 months;
5. Good Compliance;
6. Those who are willing to sign informed consent.
Exclusion Criteria
1. combined with opportunistic infections and other complications appear;
2. merger severe cardiovascular and cerebrovascular, liver, kidney and hematopoietic diseases;
3. psychiatric patients;
4. pregnant and lactating women;
5. receiving other treatments that may affect the efficacy of the test drug.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CD4+T lymphocytes;CD4+CD25+CD127low;CD8+T lymphocytes;CD8+CD38+HLA-DR+;CD4+CD38+HLA-DR+;
- Secondary Outcome Measures
Name Time Method HIV viral-load;